If you’re on a fertility journey, you’ve probably learned one thing already: Your body is complex and very smart. But sometimes stress, inflammation, age and hormone imbalances can interrupt the messages your body is trying to send.

That’s where peptides come in.

Peptides are gaining attention in fertility care because they work with your body, not against it, helping restore cellular communication so your systems can function more smoothly and efficiently.

Let’s break it down.

What Are Peptides, Anyway?

Peptides are short chains of amino acids that naturally exist in your body. Think of them as tiny messengers. Their job is to give cells instructions: when to heal, when to regulate hormones, when to calm inflammation and how to communicate with other systems in the body.

Over time, those signals can weaken. Life happens. Stress builds. Hormones shift. Inflammation creeps in.

Peptide therapy is designed to help restore those signals, supporting your body in doing what it’s already designed to do. Just more effectively.

Some peptides work through the brain’s reproductive control center (the hypothalamic-pituitary-gonadal axis), while others provide direct support to reproductive organs like the ovaries, uterus or testes.

How Peptides May Support Fertility

Because fertility involves multiple systems working together, peptides are often used as part of a whole-body, personalized approach.

Depending on your needs, peptide therapy may help support:

  • Healthy hormone signaling
  • Ovulation and cycle regularity
  • Egg quality and ovarian health
  • Uterine and endometrial lining support
  • Sperm quality and testicular function
  • Reduced inflammation and oxidative stress
  • Overall cellular energy and resilience
  • Easing shifts in mood
  • Metabolism support

They’re not a one-size-fits-all solution, and that’s actually a good thing. Peptides are typically combined with nutritional support, lifestyle support and targeted lab testing to address your unique physiology.

Is Peptide Therapy Right for You?

You may be a good candidate for fertility-focused peptide support if you:

  • Are trying to conceive naturally and want a more natural, personalized approach to fertility care
  • Plan to use, or are undergoing, assisted fertility treatments such as IVF, IUI, donor services, egg freezing or frozen embryo transfer
  • Have irregular cycles, hormone imbalances or ovulation challenges
  • Are concerned about egg or sperm quality
  • Have unexplained infertility or inflammation-related issues

Peptide therapy can be used in people with ovaries and people with sperm. It is often safely integrated alongside conventional fertility treatments when carefully monitored by a physician.

Safety First: Why Personalization Matters

When prescribed and monitored by a clinician, peptides are generally well tolerated. The key is individualization.

Your provider considers:

  • Your lab results
  • Your fertility goals
  • Your medical history
  • Where you are in your fertility timeline

Because your body is unique, there isn’t a universal peptide plan. A tailored approach ensures therapy supports your body’s specific needs. Regular tracking and adjusting to your needs are important.

Peptides Commonly Used in Fertility Care

Here’s a look at some peptides that may be incorporated into fertility-focused treatment plans, depending on individual needs.

Hormone Regulation & Ovulation Support

Kisspeptin

Kisspeptin acts in the brain to stimulate the release of GnRH, which then signals the pituitary gland to release FSH and LH, two hormones essential for egg development and ovulation.

Why it matters:
Rather than overriding your system, kisspeptin supports the body’s natural, rhythmic hormone signaling, helping promote healthier ovulation patterns.

Egg Quality & Ovarian Support

Epithalon (Epithalamin)

Epithalon is often discussed in the context of cellular aging. It helps regulate melatonin production and supports DNA repair at the cellular level.

Why it matters:
By reducing oxidative stress and supporting cellular repair, epithalon may help protect aging oocytes and support egg quality, particularly for women over 35.

Sermorelin

Sermorelin stimulates the natural secretion of growth hormone from the pituitary.

Why it matters:
Growth hormone and IGF-1 receptors can enhance follicular growth and increase ovarian responsiveness to gonadotropins.

SS-31

A synthetic tetrapeptide designed to protect mitochondria (the cell’s “powerhouse”) from oxidative stress and dysfunction by acting like an antioxidant. Egg cells contain thousands of mitochondria.

Why it matters:
Oxidative stress is a known contributor to reduced embryo development, poor IVF outcomes and age-related fertility decline.

MOTS-c

MOTS-c regulates energy metabolism and insulin sensitivity — factors closely linked to fertility.

Why it matters:
In studies, MOTS-c increased LH, FSH and testosterone levels, which suggests a role in the regulation of female and male reproductive function and (possibly) obesity-related infertility.

Uterine & Endometrial Support

BPC157

Originally derived from stomach proteins, BPC157 is known for its tissue healing properties.

Why it matters:
It supports blood vessel growth and reduces inflammation, which can help improve uterine lining health and receptivity for implantation.

GHKCu (Copper Peptide)

This peptide supports tissue repair and collagen formation.

Why it matters:
Healthy blood flow and tissue repair are essential for a receptive uterine environment — and GHKCu supports both.

Immune Modulation

Thymosin Alpha1 (Tα1)

An immune-regulating peptide.

Why it matters:
Tα1 helps regulate immune balance, supporting tolerance during implantation and early pregnancy, particularly helpful in cases of recurrent pregnancy loss or immune-related fertility challenges.

Metabolic & Hormonal Environment Support

GLP-1

GLP-1 is a naturally occurring peptide hormone involved in blood sugar regulation, metabolism, inflammation and hormone signaling.

Why it matters:
For individuals with PCOS, insulin resistance, metabolic concerns or chronic inflammation, GLP-1 support may help create a healthier internal environment for conception. It is used prior to pregnancy and typically discontinued at an appropriate time during fertility planning.

Antioxidant & Cellular Protection

Glutathione

Glutathione is a tripeptide and the body’s master antioxidant.

Why it matters:
It helps protect eggs and sperm from oxidative damage, supports mitochondrial function and plays a key role in pre-conception cellular health (making it a powerful tool for fertility optimization).

The Big Picture

Fertility isn’t about one hormone, one lab value or one cycle.

Peptides offer a way to support the body at a deeper, cellular level, helping restore communication, resilience and balance so your body is better prepared for conception and a healthy pregnancy.

If you’re curious whether peptides might be a fit for your fertility journey, a personalized consultation and lab-guided approach is the best place to start.

Your body has the wisdom. Sometimes it just needs a little support in hearing its own signals again.

Sources

  • Craik DJ, Fairlie DP, Liras S, Price D. The future of peptide-based drugs. Chem Biol Drug Des. 2013;81(1):136-147. 
  • Fosgerau K, Hoffmann T. Peptide therapeutics: current status and future directions. Drug Discov Today. 2015;20(1):122-128. 
  • Plant TM. Neuroendocrine control of the hypothalamic-pituitary-gonadal axis in reproduction. J Endocrinol. 2015;226(2):T41-T54. 
  • Clarke IJ, Cummins JT. The temporal relationship between gonadotropin releasing hormone and luteinizing hormone secretion in ovariectomized ewes. Endocrinology. 1982;111(5):1737-1739. 
  • Pinilla L, Aguilar E, Dieguez C, Millar RP, Tena-Sempere M. Kisspeptins and reproduction: physiological roles and regulatory mechanisms. Physiol Rev. 2012;92(3):1235-1316. 
  • Jayasena CN, Abbara A, Veldhuis JD, et al. Kisspeptin-54 triggers egg maturation in women undergoing in vitro fertilization. J Clin Invest. 2014;124(8):3667-3677. 
  • Tena-Sempere M. Kisspeptin signaling in the brain: recent developments and future challenges. Mol Cell Endocrinol. 2013;371(1-2):1-6. 
  • Khavinson V, Popovich I. Peptide bioregulators and aging. Neuroendocrinol Lett. 2009;30(6):706-712. 
  • Anisimov VN, Khavinson VK, Morozov VG. Effect of epitalon on lifespan and spontaneous tumor incidence in mice. Exp Gerontol. 2003;38(7):731-739. 
  • Sikiric P, Seiwerth S, Rucman R, et al. Stable gastric pentadecapeptide BPC-157: novel therapy in gastrointestinal tract and wound healing. Curr Pharm Des. 2010;16(10):1224-1237. 
  • Seiwerth S, Brcic L, Vuletic LB, et al. BPC-157 and angiogenesis in wound healing. J Physiol Pharmacol. 2018;69(6):885-899. 
  • Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. Int J Mol Sci. 2018;19(7):1987. 
  • Pickart L. The human tri-peptide GHK and tissue remodeling. J Biomater Sci Polym Ed. 2008;19(8):969-988. 
  • Garaci E, Pica F, Serafino A, et al. Thymosin alpha-1 and cancer: action on immune effector and tumor target cells. Ann N Y Acad Sci. 2007;1112:225-234. 
  • Rasi G, Terzoli E, Izzo F, et al. Thymosin alpha-1 as a biological response modifier. Expert Opin Biol Ther. 2015;15(Suppl 1):S149-S156. 
  • Li Y, Chen S, Li L, et al. Thymosin alpha-1 improves pregnancy outcomes in women with recurrent implantation failure undergoing IVF-ET. Reprod Biomed Online. 2018;36(5):594-601. 
  • Jensterle M, Janez A, Fliers E. GLP-1 receptor agonists in polycystic ovary syndrome: metabolic and reproductive effects. Endocr Rev. 2022;43(2):321-357. 
  • Rasmussen CB, Lindenberg S. The effect of GLP-1 receptor agonists on reproductive function in women with polycystic ovary syndrome. Hum Reprod Update. 2021;27(2):249-264. 
  • Agarwal A, Gupta S, Sharma RK. Role of oxidative stress in female reproduction. Reprod Biol Endocrinol. 2012;10:49. 
  • Tremellen K. Oxidative stress and male infertility: A clinical perspective. Hum Reprod Update. 2008;14(3):243-258. 
  • Showell MG, Mackenzie-Proctor R, Brown J, et al. Antioxidants for female subfertility. Cochrane Database Syst Rev. 2020;8:CD007807. 
  • Meldrum DR, Casper RF, Diez-Juan A, Simon C, Domar AD, Frydman R. Aging and the environment affect gamete and embryo potential: can we intervene? Fertil Steril. 2016;105(3):548-559. 
  • Agarwal A, Parekh N, Panner Selvam MK, et al. Male oxidative stress infertility (MOSI): proposed terminology and clinical practice guidelines. World J Mens Health. 2019;37(3):296-312. 
  • Öztürk DA, et al. Central MOTS-c infusion affects reproductive hormones in obese and non-obese rats. Neuropeptides. 2024. 
  • Wojciechowska M, et al. Changes in MOTS-c level in the blood of pregnant women. Biology (Basel). 2021. 
  • Mohtashami Z, et al. MOTS-c, the most recent mitochondrial-derived peptide in human metabolism. Int J Mol Sci. 2022. 
  • Kutuk IS, et al. Reduced serum and skeletal muscle MOTS-c levels in women with polycystic ovary syndrome are associated with mitochondrial dysfunction. Sci Rep. 2026. 
  • Nguyen ST, et al. Mitochondrial-targeted protective potential of elamipretide for the in vitro production of porcine embryos. Animals. 2025. 
  • Yao X, et al. Effect of elamipretide on the vitrification of mouse ovarian tissue. Cryobiology. 2024. 
  • Bai H, et al. Elamipretide improves sperm cryopreservation outcomes and mitochondrial stability. Cryobiology. 2020. 
  • Du X, et al. Application research of novel peptide mitochondrial drug elamipretide. Mitochondrion. 2024. 
  • Magon N. Growth hormone in the management of female infertility. J Hum Reprod Sci. 2011. 
  • Duffy JMN, et al. Growth hormone for in vitro fertilization. Cochrane Database Syst Rev. 2010. 
  • Walker RF. Sermorelin: a better approach to management of adult growth hormone deficiency. Clin Interv Aging. 2009. 
  • Â